Enwei Pharmaceutical Co Ltd (301331)

Currency in CNY
23.44
-0.01(-0.04%)
Closed·
High dividend Yield
301331 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
23.0423.86
52 wk Range
20.5639.66
Key Statistics
Bid/Ask
23.44 / 23.44
Prev. Close
23.45
Open
23.28
Day's Range
23.04-23.86
52 wk Range
20.56-39.66
Volume
1.47M
Average Volume (3m)
1.85M
1-Year Change
-27.4303%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301331 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Apr 26, 2026
EPS / Forecast
0.12 / --
Revenue / Forecast
175.33M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.46%
Dividend Yield
4.39%
Industry Median 1.78%
Annualized payout
1.03
Paid annually
5-Years Growth
-
Growth Streak

301331 Income Statement

Compare 301331 to Peers and Sector

Metrics to compare
301331
Peers
Sector
Relationship
P/E Ratio
49.6x19.6x−0.4x
PEG Ratio
18.700.250.00
Price/Book
2.2x2.1x2.6x
Price / LTM Sales
2.7x2.9x3.0x
Upside (Analyst Target)
-35.3%51.3%
Fair Value Upside
Unlock21.8%7.3%Unlock

Enwei Pharmaceutical Co., Ltd. engages in the development and sale of Chinese medicines in China. The company offers drugs in the areas of gynecology, pediatrics, and respiratory system fields. The company was founded in 2005 and is based in Chengdu, China.

Employees
1501
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.55K0.01%247.44K
Other Institutional Investors
75.22M73.83%1.76B
Public Companies & Retail Investors
26.65M26.16%624.84M
Total
101.88M100.00%2.39B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Chengdu Enwei Investment (Group) Co., Ltd.25.26%25,733,200603,444
Chengdu Jiewei Enterprise Management Co., Ltd.13.84%14,103,036330,716

FAQ

What Is the Enwei Pharmaceutical (301331) Stock Price Today?

The Enwei Pharmaceutical stock price today is 23.44 CNY.

What Stock Exchange Does Enwei Pharmaceutical Trade On?

Enwei Pharmaceutical is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for Enwei Pharmaceutical?

The stock symbol for Enwei Pharmaceutical is "301331."

Does Enwei Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Enwei Pharmaceutical dividend yield is 4.39%.

What Is the Enwei Pharmaceutical Market Cap?

As of today, Enwei Pharmaceutical market cap is 2.39B CNY.

What Is Enwei Pharmaceutical's Earnings Per Share (TTM)?

The Enwei Pharmaceutical EPS (TTM) is 0.46.

From a Technical Analysis Perspective, Is 301331 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Enwei Pharmaceutical Stock Split?

Enwei Pharmaceutical has split 1 times.

How Many Employees Does Enwei Pharmaceutical Have?

Enwei Pharmaceutical has 1501 employees.

What is the current trading status of Enwei Pharmaceutical (301331)?

As of Jul 02, 2026, Enwei Pharmaceutical (301331) is trading at a price of 23.44 CNY, with a previous close of 23.45 CNY. The stock has fluctuated within a day range of 23.04 CNY to 23.86 CNY, while its 52-week range spans from 20.56 CNY to 39.66 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.